Literature DB >> 2202842

NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer.

.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2202842

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  304 in total

1.  [An addendum to the article by C. Rödel, W. Hohenberger, R. Sauer. Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma. Strahlenther Onkol 1998; 174: 497-504 (Nr. 10)].

Authors:  C Rödel; R Sauer
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

Review 2.  Optimising treatment for resectable rectal cancer: is preoperative therapy beneficial?

Authors:  S Y Ngan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.

Authors:  Christina D Mack; William Carpenter; Anne-Marie Meyer; Hanna Sanoff; Til Stürmer
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

4.  Chemotherapy of Colorectal Cancer.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

5.  Evaluating toxicity in neoadjuvant radio-chemotherapy of rectal cancer.

Authors:  Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

Review 6.  Management of rectal cancer.

Authors:  James S Wu; Victor W Fazio
Journal:  J Gastrointest Surg       Date:  2004-02       Impact factor: 3.452

7.  Relationship between diversion colitis and quality of life in rectal cancer.

Authors:  Dong Nyoung Son; Dong Jin Choi; Si Uk Woo; Jin Kim; Bo Ra Keom; Chul Hwan Kim; Se Jin Baek; Seon Hahn Kim
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

8.  Local recurrence after rectal cancer treatment in Manitoba.

Authors:  Steven Latosinsky; Donna Turner
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

9.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

10.  Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer.

Authors:  Deniz Tural; Fatih Selcukbiricik; Özcan Yıldız; Olgun Elcin; Sibel Erdamar; Sabri Güney; Fuat Demireli; Evin Büyükünal; Süheyla Serdengeçti
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.